Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) — Cash Flow Quality Index
Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) has a Cash Flow Quality Index of 2.15x as of December 2025. Operating cash flow of TL140.82 Million exceeds net income of TL65.61 Million, indicating high earnings quality where cash backs reported profits. Explore MEDTR operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Cash Flow Quality Index (2018–2024)
Historical Cash Flow Quality Index for Meditera Tibbi Malzeme Sanayi ve Ticaret AS across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does Meditera Tibbi Malzeme Sanayi ve Ticaret generate cash.
Annual Cash Flow Quality Index for Meditera Tibbi Malzeme Sanayi ve Ticaret AS (2018–2024)
Year-by-year earnings quality comparison for Meditera Tibbi Malzeme Sanayi ve Ticaret AS.
| Year | Quality Index | Operating CF (TRY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 8.12x | TL780.69 Million | TL96.11 Million | ▼ -62.1% |
| 2023 | 21.45x | TL801.02 Million | TL37.35 Million | ▲ +124822.4% |
| 2022 | 0.02x | TL5.10 Million | TL297.05 Million | ▼ -92.1% |
| 2021 | 0.22x | TL36.64 Million | TL167.70 Million | ▼ -82.0% |
| 2020 | 1.21x | TL73.26 Million | TL60.43 Million | ▼ -22.8% |
| 2019 | 1.57x | TL20.01 Million | TL12.73 Million | ▼ -73.2% |
| 2018 | 5.87x | TL73.26 Million | TL12.49 Million | — |